KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Inventory Average (2016 - 2025)

Vertex Pharmaceuticals (VRTX) has 14 years of Inventory Average data on record, last reported at $1.7 billion in Q4 2025.

  • For Q4 2025, Inventory Average rose 45.0% year-over-year to $1.7 billion; the TTM value through Dec 2025 reached $1.7 billion, up 45.0%, while the annual FY2025 figure was $1.4 billion, 48.76% up from the prior year.
  • Inventory Average reached $1.7 billion in Q4 2025 per VRTX's latest filing, up from $1.6 billion in the prior quarter.
  • Across five years, Inventory Average topped out at $1.7 billion in Q4 2025 and bottomed at $289.8 million in Q1 2021.
  • Average Inventory Average over 5 years is $745.6 million, with a median of $607.7 million recorded in 2023.
  • Peak YoY movement for Inventory Average: grew 13.88% in 2022, then skyrocketed 70.95% in 2023.
  • A 5-year view of Inventory Average shows it stood at $343.3 million in 2021, then increased by 23.63% to $424.4 million in 2022, then soared by 68.18% to $713.8 million in 2023, then soared by 60.08% to $1.1 billion in 2024, then surged by 45.0% to $1.7 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory Average were $1.7 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.4 billion in Q2 2025.